Canine Diabetes Wiki
No edit summary
Grunny (talk | contribs)
m (Unprotected "Insuhuman Comb 50": Bot: Unprotecting page)
 
(11 intermediate revisions by one other user not shown)
Line 1: Line 1:
 
{|class="wikitable" align="right" width="300" bgcolor="powderblue"|
 
{|class="wikitable" align="right" width="300" bgcolor="powderblue"|
! colspan="2" style="background:#cae1ff; width:300px;font-size:10pt" | Insuman Comb 50
+
! colspan="2" style="background:#cae1ff; width:300px;font-size:10pt" | Insuhuman Comb 50
 
|-
 
|-
 
| colspan="2" style="background:aliceblue; width:300px; text-align:center;font-size:9pt" |[[Mixed insulins|R/Neutral/NPH/Isophane Mix]] by [[Aventis]]
 
| colspan="2" style="background:aliceblue; width:300px; text-align:center;font-size:9pt" |[[Mixed insulins|R/Neutral/NPH/Isophane Mix]] by [[Aventis]]
Line 18: Line 18:
 
| colspan="2" style="background:aliceblue; width:300px;font-size:9pt; text-align:left" | '''Line:''' [[Insuman]]
 
| colspan="2" style="background:aliceblue; width:300px;font-size:9pt; text-align:left" | '''Line:''' [[Insuman]]
 
|-
 
|-
| colspan="2" style="background:aliceblue; width:300px; font-size:9pt;text-align:left"| '''Also known as:''' [[Insuhuman Comb 50]]<br>[[Winthrop Comb 50]]
+
| colspan="2" style="background:aliceblue; width:300px; font-size:9pt;text-align:left"| '''Also known as:''' [[Insuman Comb 50]]<br>[[Winthrop Comb 50]]
   
 
|-
 
|-
Line 32: Line 32:
 
|colspan="2" style="background:aliceblue; width:300px;font-size:9pt;text-align:left"| '''In Pen:''' 4 weeks room temp.
 
|colspan="2" style="background:aliceblue; width:300px;font-size:9pt;text-align:left"| '''In Pen:''' 4 weeks room temp.
 
|-
 
|-
|colspan="2" style="background:aliceblue; width:300px;font-size:9pt;text-align:left" | '''Notes:''' Protect from light and heat<br> Do Not Freeze, [[Resuspending insulin|Resuspend]]<br> Do not use if product does not [[re-suspend]]<br>Do not use [[intravenously]]
+
|colspan="2" style="background:aliceblue; width:300px;font-size:9pt;text-align:left" | '''Notes:''' Protect from light and heat<br> Do Not Freeze, [[Resuspending insulin|Resuspend]]<br> Do not use if product does not [[re-suspend]]<br>Do not use [[intravenously]] <ref>{{cite web|title=Small Animal Clinical Pharmacology|author=Maddison, Jill E.,Page, Stephen W.,Church, David B.|year=2008|publisher=Saunders Ltd.|isbn=0702028584|page=510|url=http://www.amazon.com/Animal-Clinical-Pharmacology-Maddison-DipVetClinStud/dp/0702028584/ref=sr_1_1?s=books&ie=UTF8&qid=1296451134&sr=1-1}}</ref>
 
|}
 
|}
   
Line 42: Line 42:
 
|style="height:1px;border:0;" colspan="3"|
 
|style="height:1px;border:0;" colspan="3"|
 
|-valign="top"
 
|-valign="top"
|style="padding:5px;border:2px solid #b9f1f0;background-color:#f0f8ff;" width="90%"|
+
|style="padding:5px;border:2px solid #b9f1f0;background-color:#f0f8ff;" width="100%"|
 
'''Note that some countries have the brand name in U40 strength.'''
 
'''Note that some countries have the brand name in U40 strength.'''
 
|}
 
|}
 
This is an [[Aventis]] mixed, intermediate-acting insulin <ref>{{cite web|url=http://images4.wikia.nocookie.net/diabetesindogs/images/8/8d/Insuman_comb_50_patient_info_leaflet.pdf |title=Patient Information Leaflet-Insuman Comb 50|publisher=Sanofi-Aventis}}</ref> comprised of 50% R/neutral and 50% NPH/isophane crystal insulin <ref>{{cite web|url=http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000428/WC500029819.pdf|title=Scientific Discussion-Mixtard|publisher=EMEA}}</ref>, one of its Insuman line of products. <ref>{{cite web|url=http://www.yorkshirediabetes.com/downloads/A11456_Range_Poster.pdf |title=Aventis Poster-Insuman & Lantus Insulins|publisher=Sanofi-Aventis}}</ref><ref>{{cite web|url=http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000201/WC500033779.pdf|title=Scientific Discussion-Insuman|publisher=EMEA}}</ref>
 
This is an [[Aventis]] mixed, intermediate-acting insulin <ref>{{cite web|url=http://images4.wikia.nocookie.net/diabetesindogs/images/8/8d/Insuman_comb_50_patient_info_leaflet.pdf |title=Patient Information Leaflet-Insuman Comb 50|publisher=Sanofi-Aventis}}</ref> comprised of 50% R/neutral and 50% NPH/isophane crystal insulin <ref>{{cite web|url=http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000428/WC500029819.pdf|title=Scientific Discussion-Mixtard|publisher=EMEA}}</ref>, one of its Insuman line of products. <ref>{{cite web|url=http://www.yorkshirediabetes.com/downloads/A11456_Range_Poster.pdf |title=Aventis Poster-Insuman & Lantus Insulins|publisher=Sanofi-Aventis}}</ref><ref>{{cite web|url=http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000201/WC500033779.pdf|title=Scientific Discussion-Insuman|publisher=EMEA}}</ref>
   
[[Eli Lilly]] produced a comparable insulin for North America: [[Humulin 50/50]] <ref>{{cite web|url=http://www.revolutionhealth.com/drugs-treatments/humulin-50-50 |title=Humulin 50/50-NPH;R Human Insulin|publisher= Remedyfind.com}}</ref>; they also formerly produced this insulin in the EU & UK under the brand name [[Humulin M5]] <ref>{{cite web|url=http://www.yorkshirediabetes.com/downloads/1071_LLY_Diabetes_RangeChar.pdf |title=Lilly EU/UK Product Sheet & Time Activity Profiles|publisher=Eli Lilly}}</ref>. M5 was discontinued in July 2004 <ref>{{cite web|url=http://web.archive.org/web/20041205172554/http://www.diabetes.org.uk/infocentre/inform/insulinwithdrawal2004.htm |title=Withdrawal of Humulin M5|year=2004|publisher=Diabetes UK}}</ref>. Other Lilly insulin that are similar are [[Humulina 50/50]] and [[Humuline 50/50]].
+
[[Eli Lilly]] produced a comparable insulin for North America: [[Humulin 50/50]] <ref>{{cite web|url=http://www.revolutionhealth.com/drugs-treatments/humulin-50-50 |title=Humulin 50/50-NPH;R Human Insulin|publisher= Remedyfind.com}}</ref>; they also formerly produced this insulin in the EU & UK under the brand name [[Humulin M5]]. <ref>{{cite web|url=http://www.yorkshirediabetes.com/downloads/1071_LLY_Diabetes_RangeChar.pdf |title=Lilly EU/UK Product Sheet & Time Activity Profiles|publisher=Eli Lilly}}</ref> M5 was discontinued in July 2004. <ref>{{cite web|url=http://web.archive.org/web/20041205172554/http://www.diabetes.org.uk/infocentre/inform/insulinwithdrawal2004.htm |title=Withdrawal of Humulin M5|year=2004|publisher=Diabetes UK}}</ref> Other Lilly insulin that are similar are [[Humulina 50/50]] and [[Humuline 50/50]].
   
[[Novo Nordisk]] produced two: [[Actraphane 50/50]] <ref>{{cite web|url=http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000427/WC500025430.pdf|title=Scientific Discussion-Actraphane|publisher=EMEA}}</ref> and the now discontinued [[Mixtard 50]] <ref>{{cite web|url=http://www.leedsth.nhs.uk/sites/diabetes/information/InsulinMixtures.php |title=Insulins & Mixtures|publisher=NHS}}</ref>.
+
[[Novo Nordisk]] produced two: [[Actraphane 50/50]] <ref>{{cite web|url=http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000427/WC500025430.pdf|title=Scientific Discussion-Actraphane|publisher=EMEA}}</ref> and the now discontinued [[Mixtard 50]]. <ref>{{cite web|url=http://www.leedsth.nhs.uk/sites/diabetes/information/InsulinMixtures.php |title=Insulins & Mixtures|publisher=NHS}}</ref>
   
 
[[Mixed insulins]] cover a wide range as they can be [[:Category:Origin|animal]] origin, [[r-DNA/GE/GM]] origin or [[analog]] insulins. The non-analog mixed insulins are made up of [[:Category:Intermediate-acting|intermediate-acting]] [[NPH]]/isophane insulin and [[:Category:Short-acting|short-acting]] [[R]]/neutral. normal insulin. The analog mixes are made from [[:Category:Intermediate-acting|intermediate-acting]] protamine-suspended analog insulin (suspended similar to NPH/isophane insulin) and [[:Category:Fast-acting|fast-acting]] analog insulin. They can also vary in the fraction (amount or percent) of the two types (R/neutral and NPH/isophane) of insulin used to make a non-analog mix, and in the percentage of fast/rapid-acting analog insulin and slower-acting protamine suspended analog insulin.
 
[[Mixed insulins]] cover a wide range as they can be [[:Category:Origin|animal]] origin, [[r-DNA/GE/GM]] origin or [[analog]] insulins. The non-analog mixed insulins are made up of [[:Category:Intermediate-acting|intermediate-acting]] [[NPH]]/isophane insulin and [[:Category:Short-acting|short-acting]] [[R]]/neutral. normal insulin. The analog mixes are made from [[:Category:Intermediate-acting|intermediate-acting]] protamine-suspended analog insulin (suspended similar to NPH/isophane insulin) and [[:Category:Fast-acting|fast-acting]] analog insulin. They can also vary in the fraction (amount or percent) of the two types (R/neutral and NPH/isophane) of insulin used to make a non-analog mix, and in the percentage of fast/rapid-acting analog insulin and slower-acting protamine suspended analog insulin.
Line 89: Line 89:
   
 
==References==
 
==References==
  +
{{Reflist|colwidth=30em}}
<references/>
 
 
   
 
==More Information==
 
==More Information==
Line 96: Line 95:
 
*[http://www.yorkshirediabetes.com/downloads/A11456_Range_Poster.pdf Chart of Insuman Insulin Ranges] Yorkshire Diabetes
 
*[http://www.yorkshirediabetes.com/downloads/A11456_Range_Poster.pdf Chart of Insuman Insulin Ranges] Yorkshire Diabetes
 
*[http://images2.wikia.nocookie.net/__cb20100821055615/diabetesindogs/images/0/0a/NACDS_insulin_chart.pdf NACDS-Insulin Chart-Page 2]
 
*[http://images2.wikia.nocookie.net/__cb20100821055615/diabetesindogs/images/0/0a/NACDS_insulin_chart.pdf NACDS-Insulin Chart-Page 2]
  +
  +
  +
<center>'''Related pages'''</center>
  +
{|align="center" width="600"
  +
  +
|<center>[[Image:Humulin M5.JPG|90px]]</center>
  +
|<center>[[Image:Penfill Mixtard 50 1.jpg|120px]]</center>
  +
|<center>[[Image:Humu515m.jpg|120px]]</center>
  +
|<center>[[Image:Wp comb50 1.GIF|120px]]</center>
  +
  +
|-
  +
|<center>[[Humulin M5]]</center>
  +
|<center>[[Mixtard 50]]</center>
  +
|<center>[[Humulin 50/50]]</center>
  +
|<center>[[Penmix 50]]</center>
  +
  +
|}
  +
[[Category:50-50]]
 
[[Category:Content]]
 
[[Category:Content]]
 
[[Category:Insulins]]
 
[[Category:Insulins]]

Latest revision as of 23:24, 23 May 2012

Insuhuman Comb 50
R/Neutral/NPH/Isophane Mix by Aventis
intermediate-acting
r-DNA/GE/GM
U40, U100 isophane
Action in dogs:
  • onset 0.5-3h,
  • peak 2-10h,
  • duration 4-24h
Line: Insuman
Also known as: Insuman Comb 50
Winthrop Comb 50
Similar to: Huminsulin 50/50,Humulin M5
Humulin 50/50,Humulina 50/50, Humuline 50/50
Actraphane 50/50, Mixtard 50, Penmix 50 [1]

Names of Lilly r-DNA/GE/GM insulins worldwide
Use and Handling:
Shelf Life: 24 months Type: cloudy
When Opened: 4 weeks room temp.
In Pen: 4 weeks room temp.
Notes: Protect from light and heat
Do Not Freeze, Resuspend
Do not use if product does not re-suspend
Do not use intravenously [2]
Wp comb50 1

Time activity profile for 50/50 insulins.


Note that some countries have the brand name in U40 strength.

This is an Aventis mixed, intermediate-acting insulin [3] comprised of 50% R/neutral and 50% NPH/isophane crystal insulin [4], one of its Insuman line of products. [5][6]

Eli Lilly produced a comparable insulin for North America: Humulin 50/50 [7]; they also formerly produced this insulin in the EU & UK under the brand name Humulin M5. [8] M5 was discontinued in July 2004. [9] Other Lilly insulin that are similar are Humulina 50/50 and Humuline 50/50.

Novo Nordisk produced two: Actraphane 50/50 [10] and the now discontinued Mixtard 50. [11]

Mixed insulins cover a wide range as they can be animal origin, r-DNA/GE/GM origin or analog insulins. The non-analog mixed insulins are made up of intermediate-acting NPH/isophane insulin and short-acting R/neutral. normal insulin. The analog mixes are made from intermediate-acting protamine-suspended analog insulin (suspended similar to NPH/isophane insulin) and fast-acting analog insulin. They can also vary in the fraction (amount or percent) of the two types (R/neutral and NPH/isophane) of insulin used to make a non-analog mix, and in the percentage of fast/rapid-acting analog insulin and slower-acting protamine suspended analog insulin.

For some reason, those in the US choose to list the slower, NPH/isophane based insulin fraction first, such as Humulin or Novolin 70/30. The rest of the world gives the faster insulin top billing and the result is 30/70. Regardless of how this is written, it means that the insulin is made up of 70% NPH/isophane insulin and 30% R/neutral insulin.

The most common mixes are 70/30 (30/70) (non analog) or 75/25 (25/75) (analog). There are no currently-marketed mixes which combine insulins of different origins. Eli Lilly's form of beef/pork Iletin and Novo Nordisk's Lentard were discontinued some time ago. Here are the most common ones that could cause confusion:

References[]

More Information[]


Related pages
Humulin M5
Penfill Mixtard 50 1
Humu515m
Wp comb50 1
Humulin M5
Mixtard 50
Humulin 50/50
Penmix 50